Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.21.2
Stockholders' Equity
3 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Stockholders’ Equity

Note 8. Stockholders’ Equity

 

Equity Offering Program

 

The Company has in place an ATM Equity OfferingSM Sales Agreement with BofA Securities, Inc. and Piper Sandler & Co. (the “Sales Agreement”), pursuant to which the Company may sell from time-to-time shares of its common stock having an aggregate offering price of up to $100,000,000 (the “Equity Offering Program”).

 

The following table summarizes sales through the Equity Offering Program during the quarter ended September 30, 2021:

 

Three months ended   Avg price
per share
    Number of
Shares
    Gross
Proceeds
(in millions)
    Offering
Expenses
(in millions)
    Net
Proceeds
(in millions)
 
September 30, 2021   $ 9.99       555,455     $           5.5     $        0.1     $         5.4  
Total             555,455     $ 5.5     $ 0.1     $ 5.4  

 

Equity Incentive Plans

 

During the three months ended September 30, 2021, the Company granted employees options to purchase an aggregate of approximately 0.4 million shares of common stock. The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following assumptions:

 

    Three Months
Ended
September 30,
2021
 
Exercise price   $ 9.18 –10.15  
Expected term (years)     4.75 – 5.00  
Volatility     67 %
Risk-free interest rate     0.76%–0.81 %
Dividend yield     0 %
Weighted Average Grant Date Fair Value of Options granted during the period   $ 5.53  

  

During the three months ended September 30, 2021 the Company awarded certain employees and directors grants of an aggregate of approximately 0.6 million restricted stock units (“RSUs”) with a weighted average grant date fair value of $9.99. The RSUs will be expensed over the requisite service period. The terms of the RSUs include vesting provisions based solely on continued service. If the service criteria are satisfied, the RSUs will generally vest over 4 – 5 years.

 

Compensation expense related to our stock-based awards described above was as follows (in thousands):

 

    Three Months Ended
September 30,
 
    2021     2020  
Research and Development   $ 1,232     $       1,014  
General and Administrative     1,116       1,013  
Total   $ 2,348     $ 2,027  

 

Unrecognized stock-based compensation expense and weighted-average years to be recognized are as follows (in thousands):

 

    As of September 30, 2021  
    Unrecognized
stock-based
compensation
    Weighted-
average years
to be recognized
 
Options   $        4,056               2.55  
Restricted stock units   $ 12,386       2.51